论文部分内容阅读
本刊讯南京红太阳股份有限公司近日宣布,根据公司全资子公司重庆华歌生物化学有限公司(以下简称“重庆华歌”)经营发展需要,拟由公司全资子公司红太阳国际贸易(上海)有限公司(以下简称“红太阳上海公司”)对重庆华歌增资人民币2.12亿元。增资后,重庆华歌注册资本由人民币3.18亿元增加至人民币5.3亿元,红太阳股份持有重庆华
According to the business development needs of Chongqing Huacai Biochemical Co., Ltd., a wholly-owned subsidiary of the Company (hereinafter referred to as “Chongqing Huacai”), Nanjing Hongsheng Sun Co., Ltd. recently announced that it plans to be wholly owned by the Company’s subsidiary, Red Sun International Trading (Shanghai) Co., Ltd. (hereinafter referred to as “Red Sun Shanghai”) made a capital increase of RMB212 million to Chongqing Huge. After the capital increase, the registered capital of Chongqing Huge increased from RMB318 million to RMB530 million. The Red Sun Shares held the shares of Chongqing Hua